RYEAX | VENAX | RYEAX / VENAX | |
Total Expense Ratio | 1.65 | 0.09 | 1,833% |
Annual Report Gross Expense Ratio | 1.68 | 0.09 | 1,867% |
Fund Existence | 27 years | 21 years | - |
Gain YTD | 2.184 | 2.194 | 100% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 100000 | 3% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 18.9M | 8.68B | 0% |
Annual Yield % from dividends | 4.47 | 3.27 | 137% |
Returns for 1 year | -3.93 | -3.33 | 118% |
Returns for 3 years | 12.11 | 12.82 | 94% |
Returns for 5 years | 159.91 | 156.18 | 102% |
Returns for 10 years | 16.84 | 27.15 | 62% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LIBD | 263.22 | N/A | N/A |
LifeX 2065 Inflation-Protected Longevity Income ETF | |||
GSEW | 83.59 | -0.16 | -0.19% |
Goldman Sachs Equal Wght US Lg Cp Eq ETF | |||
FAD | 150.09 | -0.79 | -0.53% |
First Trust Multi Cap Gr AlphaDEX® ETF | |||
SBIO | 32.83 | -0.29 | -0.89% |
ALPS Medical Breakthroughs ETF | |||
GLIV | 7.90 | -0.35 | -4.24% |
Grayscale Livepeer Trust (LPT) |